Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies

Fatty Acids and Outcomes Research Consortium (FORCE)

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

The health effects of omega-3 fatty acids have been controversial. Here we report the results of a de novo pooled analysis conducted with data from 17 prospective cohort studies examining the associations between blood omega-3 fatty acid levels and risk for all-cause mortality. Over a median of 16 years of follow-up, 15,720 deaths occurred among 42,466 individuals. We found that, after multivariable adjustment for relevant risk factors, risk for death from all causes was significantly lower (by 15-18%, at least p < 0.003) in the highest vs the lowest quintile for circulating long chain (20-22 carbon) omega-3 fatty acids (eicosapentaenoic, docosapentaenoic, and docosahexaenoic acids). Similar relationships were seen for death from cardiovascular disease, cancer and other causes. No associations were seen with the 18-carbon omega-3, alpha-linolenic acid. These findings suggest that higher circulating levels of marine n-3 PUFA are associated with a lower risk of premature death.

Original languageEnglish
Article number2329
Pages (from-to)1-9
Number of pages9
JournalNature Communications
Volume12
DOIs
Publication statusPublished - 22 Apr 2021

Bibliographical note

Copyright:
This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine

Fingerprint

Dive into the research topics of 'Blood n-3 fatty acid levels and total and cause-specific mortality from 17 prospective studies'. Together they form a unique fingerprint.

Cite this